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H I G H L I G H T S
• E-cigarettes (40.7%) were most likely to be seen as less harmful than cigarettes
• Hookah (17.8%) was next most likely to be seen as less harmful than cigarettes
• Belief that cigarettes are harmful associated with using hookah
• Product users more likely to believe their product less harmful than cigarettes
A R T I C L E I N F O
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A B S T R A C T
Introduction: This study is the first nationally representative survey of U.S. adults (18+) to examine perceptions
of the relative harms of eight non-cigarette tobacco products.
Methods: Data are from Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study Adult
Questionnaire, a nationally representative study of 32,320 adults in the United States conducted from September
2013 to December 2014.
Results: 40.7% of adults believed that electronic cigarettes were less harmful than cigarettes, and 17.8% of
adults believed that hookah was less harmful than cigarettes. Those less knowledgeable about the health risks of
smoking were more likely to believe that the non-cigarette products were less harmful than cigarettes. Current
non-cigarette tobacco product users were more likely to perceive that product to be less harmful than cigarettes
(except filtered cigars). There was a significant positive correlation between beliefs that cigarettes were harmful
and the likelihood of using hookah; perceptions of the harmfulness of cigarettes was not associated with the
likelihood of using any other product.
Conclusions: Perceptions of harmfulness varied widely across non-cigarette tobacco products. E-cigarettes and
hookah in particular are seen as less harmful compared to cigarettes.
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1. Background
The Family Smoking Prevention and Tobacco Control Act (TCA)
enacted in 2009 granted the Food and Drug Administration (FDA)
regulatory authority over “the manufacture, marketing, and distribu-
tion of tobacco products.” (Family Smoking Prevention and Tobacco
Control Act, n.d.) In addition, FDA finalized a rule, effective August
2016 that extended its authority to all products that meet the definition
of a tobacco product including e-cigarettes, cigars, pipes, and water
pipes/hookahs (Hyland et al., 2017). Included in the provisions are a
national minimum age for sales, required health warnings, tobacco
product ingredient reporting, and reporting of harmful and potentially
harmful constituents.
Understanding public perceptions about tobacco products can help
to inform the FDA as it develops policies and regulations for tobacco
products and the marketing of those products. The Population
Assessment of Tobacco and Health (PATH) Study is a nationally re-
presentative, longitudinal cohort study of adults and youth in the U.S.,
designed to inform and monitor the impact of FDA's regulatory actions
to reduce tobacco-related death and disease (Bansal-Travers et al.,
2011a). Its sampling design, cohort design, and very large sample size
endows the PATH Study with the potential for more rigorous in-
vestigations of perceptions that the US public holds of cigarettes and of
non-cigarette tobacco products. In recent years, the range of non-ci-
garette tobacco products, especially in the class of e-cigarettes, has
expanded greatly, and in this new and more complex market of tobacco
products it is even more important to understand consumer perceptions
about these tobacco products.
Perceptions of harmfulness are important determinants of tobacco
product selection (Kaufman et al., 2011), quit intentions (Costello et al.,
2012), and quitting behavior (Pollay & Dewhirst, 2002). Perceptions of
the relative harmfulness of different types of tobacco products are in-
fluenced, in part, by advertising (e.g. historical messages with explicit
and implicit health claims) (Hammond & Parkinson, 2009), packaging
and labelling (e.g., package colors, historical brand descriptors such as
“light” and “low tar”) (Kaufman et al., 2011; Elton-Marshall et al.,
2010), and consumer reactions to trying a product (i.e., chemosensory
responses—taste, harshness) (Bansal-Travers et al., 2011b). Product
harm perceptions are important to understand since they are predictors
of whether people will be interested in trying a product or not
(Kaufman et al., 2011; Hastrup et al., 2001; U.S. Department of Health
and Human Services, Public Health Service, National Institutes of
Health, National Cancer Institute. Monograph 13, 2001). For example,
perceptions that filtered and low tar/nicotine brand cigarettes were less
harmful was an important factor in the market growth of filtered and
low tar/nicotine cigarettes (Hammond & Parkinson, 2009; Choi &
Forster, 2014). Similarly, among young adults the uptake of electronic
cigarettes has been linked to the perception that these products provide
lower overall health risks compared to cigarettes (Kaufman et al.,
2015).
Studies comparing perceptions of the relative harmfulness of dif-
ferent tobacco products to cigarettes have found that e-cigarettes
(Pearson et al., 2012; Aljarrah et al., 2009) and hookah (Smith-Simone
et al., 2008; Sutfin et al., 2011; Cohn et al., 2015) are perceived to be
less harmful than cigarettes. Cigars, cigarillos, and little cigars are
perceived as just as harmful as cigarettes (Nyman et al., 2002; Sterling
et al., 2013; Kaufman et al., 2014). Non-combusted tobacco products
including snus, smokeless tobacco, and dissolvables are perceived as
just as harmful as or more harmful than cigarettes (Kiviniemi &
Kozlowski, 2015; O'Connor et al., 2007; Richardson et al., 2014;
Borland et al., 2011; Minaker et al., 2015).
Cigarette smokers (relative to non-smokers) (Sutfin et al., 2013) and
users of e-cigarettes (Borland et al., 2011; Eissenberg et al., 2009),
hookah (Weinstein et al., 2005), and smokeless tobacco (including snus
and snuff) (Richardson et al., 2014; Borland et al., 2011; Minaker et al.,
2015) dissolvables (Borland et al., 2011), cigars (Sterling et al., 2013),
little cigars and cigarillos (Nyman et al., 2002), relative to non-users
were more likely to believe that these products were less harmful than
cigarettes. These findings are in line with previous observations that
many tobacco users are subject to an optimism bias and therefore to-
bacco users may be more likely to underestimate their health risks
compared to non-users (Berg et al., 2015).
Comparing across multiple combusted tobacco products, a nation-
ally representative survey (conducted from 2002 to 2004) found that
among the U.S. adult sample of 13,322 smokers, 22.2% reported that
some combusted tobacco products were less harmful than others
(Richardson et al., 2014). Another study (conducted in 2013) used a
sample of 10,000 students in two U.S. universities and found that across
multiple combusted and non-combusted tobacco products, e-cigarettes
were rated the least harmful to health followed by hookah, cigarettes,
and cigar products, whereas smokeless tobacco was rated as the most
harmful (Zeller & Hatsukami, 2009). These findings indicate that per-
ceptions of the harmfulness of tobacco products may not correspond
with the current scientific evidence on the levels of toxicants in tobacco
products (O'Connor et al., 2007; Minaker et al., 2015) which has de-
monstrated that in general combustible tobacco products are more
harmful to long-term users than non-combustible tobacco products
(Bernat et al., 2017).
A limitation of the existing research is that the majority of studies
are not nationally representative, or rely on convenience samples
(Kaufman et al., 2015; Smith-Simone et al., 2008; Sutfin et al., 2011;
Cohn et al., 2015; Nyman et al., 2002; Sterling et al., 2013; Kaufman
et al., 2014; Borland et al., 2011; Eissenberg et al., 2009; Weinstein
et al., 2005). Further, whereas previous research has examined risk
perceptions of non-cigarette tobacco products typically one at a time
(e.g. perceptions of e-cigarettes (Aljarrah et al., 2009) or a few products
at a time (e.g. risk perceptions of e-cigarettes and smokeless tobacco
(O'Connor et al., 2007), this study examines risk perceptions across
multiple products in a single study therefore allowing comparisons of
the relative percpetions of the harmfulness of different products (by
controlling for differences in samples and sampling design) (O'Connor
et al., 2007; Richardson et al., 2014; Borland et al., 2011; Minaker
et al., 2015). Additionally, a study by Bernat et al. (Bernat et al., 2017)
examined absolute perceptions of the harmfulness of seven tobacco
products in a single study (Weaver et al., 2016). Research has demon-
strated that there are differences in perceptions of harm according to
whether an absolute or a relative risk is examined. Therefore, the cur-
rent study will complement research by Bernet et al. (Bernat et al.,
2017) by examining perceptions of the relative harmfulness of tobacco
products compared to cigarettes across eight different products (Aim 1)
(Weaver et al., 2016). Additionally, (Weaver et al., 2016) examined
awareness and use of tobacco products but did not examine factors
associated with risk perceptions of these different products and this
study may be limited by its sampling design (an internet panel) (United
States Department of Health and Human Services. National Institutes of
Health, n.d.). The study will therefore address this gap by using a large,
robust, nationally representative face-to-face study examining how
perceptions of the relative harmfulness of tobacco products relate to use
(Aim 3). Finally, the existing research studies are mostly descriptive
(Smith-Simone et al., 2008; Sutfin et al., 2011; Sterling et al., 2013;
O'Connor et al., 2007) and few examine the factors associated with
harm perceptions of multiple products (Aim 2) (Richardson et al., 2014;
Borland et al., 2011; Minaker et al., 2015) and there is a lack of research
examining how perceptions of the harmfulness of cigarettes are related
to product use among adults (Aim 4).
The current study is the first to utilize a nationally representative
sample of U.S. adults (ages 18 years and older) to examine perceptions
of the relative harms of eight non-cigarette tobacco products: e-cigar-
ettes, hookah, traditional cigars, filtered cigars, cigarillos, pipe, smo-
keless tobacco, and dissolvables. This study has four aims: (Family
Smoking Prevention and Tobacco Control Act, n.d.) to measure per-
ceptions of the harmfulness of eight non-cigarette tobacco products
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relative to cigarettes and to determine how these perceptions vary
across these products; (Hyland et al., 2017) to identify the character-
istics of U.S. adults that are associated with perceptions of harmfulness
of non-cigarette tobacco products, especially the characteristics related
to perceiving that a particular non-cigarette tobacco product is less
harmful (vs. no different or more harmful) than cigarettes; (Bansal-
Travers et al., 2011a) to determine the relation between perceived
harmfulness of each non-cigarette tobacco product and the likelihood of
using that product; and (Kaufman et al., 2011) to measure the per-
ceptions of harmfulness of cigarettes and determine how these per-
ceptions vary as a function of products used.
2. Methods
Data are fromWave 1 of the PATH Study conducted from September
12, 2013 to December 15, 2014 and analyzed in 2016. The PATH Study
is a nationally representative, longitudinal cohort study of 45,971
adults and youth in the U.S., ages 12 years and older. The National
Institutes of Health, through the National Institute on Drug Abuse, is
partnering with the FDA's Center for Tobacco Products to conduct the
PATH Study under a contract with Westat. This cross sectional analysis
is based on 32,320 Wave 1 adult (18 years and older) interviews and
subsets of those adults who were aware of different types of non-ci-
garette tobacco products.
Recruitment employed address-based, area-probability sampling,
using an in-person household screener to select youths and adults.
Adult tobacco users, young adults aged 18 to 24, and African Americans
were oversampled relative to population proportions. The PATH Study
used Audio-Computer Assisted Self-Interviews (ACASI) available in
English and Spanish to collect information on tobacco-use patterns and
associated health behaviors.
The weighting procedures adjusted for oversampling and non-
response; combined with the use of a probability sample, the weighted
data allow the estimates produced by Wave 1 of the PATH Study to be
representative of the non-institutionalized, civilian U.S. population. The
weighted response rate for the household screener was 54.0%. Among
households that were screened, the overall weighted response rate was
74.0% for the Adult Interview. Further details regarding the PATH
Study design and methods are available in Hyland et al. (Hyland et al.,
2017) (Bansal-Travers et al., 2011a) and on the PATH Study's website
(www.pathstudyinfo.nih.gov) (Kasza et al., 2013a). Westat's Institu-
tional Review Board approved the study design and protocol and the
Office of Management and Budget approved the data collection.
3. Measures
3.1. Awareness of tobacco products
Respondents were given a brief description and shown pictures of
tobacco products (except cigarettes) and asked whether they had seen
or heard of each of the following: an electronic cigarette (or e-cigar-
ette), traditional cigars, cigarillos and filtered cigars, hookah, pipes,
dissolvable tobacco, and smokeless tobacco such as snus pouches, loose
snus, moist snuff, dip, spit or chewing tobacco. Only respondents who
had heard of the non-cigarette product that was being measured were
asked subsequent questions about perceptions of harm and use of that
product.
3.2. Perceptions of harmfulness
For each product, respondents were asked: “is smoking (insert one
of the following: traditional cigars, filtered cigars, cigarillos, pipes,
Table 1
Awareness and perceptions of the harmfulness (relative to cigarettes) of the eight non-cigarette tobacco products (n=32,320). SOURCE: PATH Study Wave 1.
Product Aware of product % (95% CI) Perception of harmfulness Unweighted frequency
Weighted estimates % (95% CI)
E-cigarettes 85.7 (84.9–86.3) Less harmful 13,728 40.7 (39.8–41.5)
About the same 12,715 47.3 (46.6–48.0)
More harmful 1831 6.9 (6.4–7.3)
Don't know 1051 5.1 (4.7–5.6)
Smokeless tobacco 81.6 (80.9–82.3) Less harmful 2573 8.6 (8.1–9.1)
About the same 16,405 60.9 (60.0–61.7)
More harmful 7635 27.6 (26.8–28.4)
Don't know 643 3.0 (2.7–3.4)
Traditional cigars 66.0 (65.2–66.9) Less harmful 2438 12.1 (11.5–12.8)
About the same 10,616 61.7 (60.6–62.8)
More harmful 5075 23.9 (22.8–24.9)
Don't know 319 2.3 (2.0–2.6)
Filtered cigars⁎ 81.6 (80.6–82.5) Less harmful 1933 7.6 (7.2–8.0)
About the same 18,536 75.5 (74.8–76.3)
More harmful 4410 14.5 (13.9–15.2)
Don't know 437 2.3 (2.0–2.7)
Cigarillos⁎ Less harmful 1990 7.1 (6.7–7.6)
About the same 16,967 70.7 (70.0–71.5)
More harmful 5908 19.8 (19.1–20.5)
Don't know 445 2.4 (2.1–2.7)
Pipe 89.6 (89.0–90.2) Less harmful 3250 10.3 (9.8–10.9)
About the same 18,520 66.8 (66.0–67.6)
More harmful 6730 20.1 (19.5–20.8)
Don't know 622 2.8 (2.5–3.1)
Hookah 70.3 (69.4–71.1) Less harmful 6118 17.8 (17.1–18.6)
About the same 14,423 61.5 (60.6–62.4)
More harmful 4222 16.7 (16.0–17.4)
Don't know 706 4.0 (3.6–4.5)
Dissolvables 10.9 (10.5–11.4) Less harmful 648 13.5 (12.2–14.9)
About the same 2670 62.0 (60.0–64.0)
More harmful 932 22.1 (20.2–24.1)
Don't know 94 2.4 (1.7–3.3)
⁎ Awareness was assessed for filtered cigars and cigarillos combined.
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hookah) less harmful, about the same, or more harmful than smoking
cigarettes?” Response options were “less harmful”, “about the same”,
and “more harmful”. If respondents skipped this question they were
given the option of saying “don't know”. The frequency of responding
“don't know” for each product is provided in Table 1. Questions for e-
cigarettes, smokeless tobacco, and dissolvables replaced “smoking”
with “using”. Note that questions about use of snus pouches and smo-
keless tobacco were asked separately whereas perceptions of relative
harm were only asked about “smokeless tobacco” generally. Based on
each of the perceived harm variables, we created binary versions for
less harmful (1= less harmful and 0=more/the same/don't know)
and more harmful (1=more harmful and 0= less/the same/don't
know).
Perceived harmfulness of cigarettes was measured by asking “how
harmful do you think cigarettes are to health?”; response options (“not
at all harmful,” “slightly harmful,” “somewhat harmful,” “very
harmful,” and “extremely harmful”) were coded 1= very or extremely
harmful and 0=not at all/slightly/somewhat harmful.
3.3. Current use of products
Former tobacco users were former established or former experi-
mental users of cigarettes or any non-cigarette tobacco product (derived
variables in the PATH Study's Restricted Use File [RUF]) (Kasza et al.,
2013b; Yang et al., 2010). Current users of non-cigarette tobacco pro-
ducts were identified as those who currently used any tobacco product
irrespective of how frequently they used it. Respondents who were not
current or former users were classified as non-users. Non-users had to
indicate that they did not use all 10 products to be considered non-users
because otherwise they may still use the product but skipped the
question. Respondents who said that they used ANY of the products
were classified as a user because there was sufficient information to
make that classification. Of 32,320, 2.1% (689) could not be classified
as a result of the classification system we used. “Never” and “low level”
users were used to define the “non-user” category.
3.4. Covariates
Demographic measures included: sex, age (derived using the im-
puted variable in the RUF), race/ethnicity (derived using the imputed
variable in the RUF), sexual orientation, educational attainment, and
household income. Missing data on age, gender, race, Hispanic ethni-
city were logically assigned from household screener data, as described
in the PATH Study Restricted Use File User's Guide (United States
Department of Health and Human Services. National Institutes of
Health, n.d.. http://doi.org/10.3886/ICPSR36231.v2). Current tobacco
use status was also a covariate (non-user “does not use any tobacco
product,” “former tobacco user,” and “current tobacco user”).
Respondents who had never smoked (not even once) and those who had
used< 100 cigarettes in their lifetime were classified as non-smokers.
Respondents who used cigarettes everyday were classified as daily
smokers and respondents who used cigarettes on some days were
classified as non-daily smokers. All categories and reference groups for
each variable are provided in Table 2.
Consistent with existing research (Popova & Ling, 2013), we con-
structed a knowledge index examining whether the respondent believed
that cigarette smoking causes: (Family Smoking Prevention and
Tobacco Control Act, n.d.) stroke, (Hyland et al., 2017) lung cancer,
(Bansal-Travers et al., 2011a) heart disease, (Kaufman et al., 2011)
blindness, (Costello et al., 2012) poor circulation, (Pollay & Dewhirst,
2002) bladder cancer, (Hammond & Parkinson, 2009) mouth cancer,
(Elton-Marshall et al., 2010) lung disease, (Bansal-Travers et al., 2011b)
lung disease in non-smokers, (Hastrup et al., 2001) heart attack in non-
smokers, and (U.S. Department of Health and Human Services, Public
Health Service, National Institutes of Health, National Cancer Institute.
Monograph 13, 2001) fetal harm. All respondents to the survey were
asked these questions. Affirmative responses were coded as being
knowledgeable of the harm (=1); the index was then created as the
sum of all items and ranged from 0 to 11.
3.5. Statistical analysis
Analyses were conducted using SAS version 9.3. Statistical methods
appropriate for complex survey data were used to estimate for each
non-cigarette tobacco product the percentage of U.S. adults believing
that product to be less harmful than cigarettes. Variances were esti-
mated using Balanced Repeated Replication (BRR) with a Fay adjust-
ment factor of 0.3. Estimates were weighted to be representative of the
U.S. adult population. Logit confidence limits (95% confidence inter-
vals) were estimated for descriptive statistics only through the use of
PROC SURVEYFREQ. An omnibus test for each covariate was used to
determine the significance of each factor in logistic regression models
using odds ratios.
Aim 1: Differences in perceptions between products were tested
using multivariable logistic regression. The outcome for this analysis
was the “product harmfulness” variable and all pairwise differences in
the odds of each product being less (or more) harmful than cigarettes
were estimated. A “step down” approach was used to test specific
contrasts (shown in Fig. 1) specifically by comparing the largest pro-
portion of respondents believing that the product was less harmful to
the second largest to the third, etc., which yielded seven comparisons:
e-cigarette vs. hookah, hookah vs. dissolvables, dissolvables vs. tradi-
tional cigars, traditional cigars vs. pipe, pipe vs. smokeless, smokeless
vs. filtered cigars, and filtered cigars vs. cigarillos. A second analysis
using this model examined the belief that each product was more
harmful. Models controlled for all demographic variables and overall
knowledge of the harms of cigarette smoking. Tests were adjusted for
multiple comparisons using a Bonferroni correction. The model here is
based on a type of repeated measures analysis, where each respondent
aware of one or more products was included in the analysis.
Aim 2: Multivariable logistic regression models were used to ex-
amine the factors associated with believing each of the non-cigarette
tobacco products were “less harmful than cigarettes”; these models
adjusted for demographic variables and knowledge of the health harms
caused by cigarette smoking. Only those who were aware of the product
were included in the model. Sample sizes for each model are shown in
Table 2.
Aim 3: Multivariable logistic regression models were used to ex-
amine whether perceptions of harmfulness of a product were associated
with use of that product; these models adjusted for demographic vari-
ables (excluding current tobacco use) and cigarette smoking status.
Given our interest in examining whether respondents had an opinion of
harm related to use, for analyses examining product use as an outcome,
respondents who said “don't know” for the harmfulness of the product
were excluded. The total sample size differed according to product but
ranged from 16,413 for traditional cigars to 25,536 for pipes.
Aim 4: Descriptive statistics appropriate for complex survey data
were used to estimate the proportion of respondents who used each
non-cigarette tobacco or cigarette product if they believed that cigar-
ettes were not at all/slightly or somewhat harmful and if they believed
that cigarettes were very/extremely harmful. Only current users of any
of the non-cigarette tobacco products or cigarettes were included in this
analysis (n=17,690).
4. Results
Among current tobacco users, cigarettes were perceived as being
“very” or “extremely harmful” (77.0%). Descriptive statistics of the
sample are presented in Supplemental Table S1.
Table 1 presents both awareness and perception of harmfulness of
each non-cigarette tobacco product among the U.S. population.
Awareness was highest for pipes (89.6%) and e-cigarettes (85.7%).
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Fig. 1 presents the percentage of the population who believed that
each product is less harmful than cigarettes (among those who had
heard of that product) (Fig. 1); and more harmful than cigarettes
(Fig. 1b). E-cigarettes were most likely to be perceived as less harmful
than cigarettes (40.7%), followed by hookah (17.8%), dissolvables
(13.5%), traditional cigars (12.1%), pipes (10.3%), smokeless tobacco
(8.6%), filtered cigars (7.6%), and cigarillos (7.1%) (Fig. 1). Turning to
perceptions that a product was more harmful than cigarettes, smokeless
tobacco was most likely to be perceived as more harmful than cigar-
ettes, followed by traditional cigars, dissolvables, pipes, cigarillos,
hookah, filtered cigars, and e-cigarettes (Fig. 1b). Within Fig. 1, dif-
ferent letters shown in parentheses indicate significant differences in
harmfulness beliefs between products, as tested in the logistic regres-
sion analyses.
Table 2 presents the factors associated with the belief that each non-
cigarette tobacco product is less harmful than cigarettes. The only
factor associated with perceptions of harmfulness across all of the
products was knowledge about the health risks of smoking. Those less
knowledgeable about the health risks were significantly more likely to
believe that each non-cigarette tobacco product was less harmful than
cigarettes. Additionally, with the exception of hookah, male re-
spondents were significantly more likely than female respondents to
believe that each non-cigarette product was less harmful. Of note,
young adults (Cohn et al., 2015; Nyman et al., 2002; Sterling et al.,
2013; Kaufman et al., 2014; Kiviniemi & Kozlowski, 2015; O'Connor
et al., 2007; Richardson et al., 2014) were significantly more likely than
older adults to believe that e-cigarettes and hookah were less harmful
than cigarettes. Other factors associated with perceptions of the relative
harmfulness of non-cigarette tobacco products varied by product type.
For example, those who were younger, higher educated, have higher
income levels, and current or former tobacco users were more likely to
say e-cigarettes were less harmful compared to cigarettes. Black,
American Indian/Alaska Native, Asian, and Hispanic ethnicities were
less likely than whites to believe that e-cigarettes were less harmful
than cigarettes. A different pattern of predictors was seen for other
tobacco products, as illustrated in Table 2. Factors associated with
perceptions that each product is more harmful than cigarettes are
presented in Supplemental Table 2. Black and Hispanic respondents
were significantly more likely than White respondents to believe that
each of the products is more harmful than cigarettes. No other factors
consistently predicted perceptions of greater harm across all non-ci-
garette tobacco products.
Perceptions of the harmfulness of a non-cigarette tobacco product
were related to whether or not the product was used (data not shown in
tables). Respondents who perceived a tobacco product as less harmful
than cigarettes were more likely to use that product: e-cigarettes
(OR=3.20., 95% CI 2.91–3.51), hookah (OR=3.19, 95% CI
2.82–3.60), traditional cigars (OR=3.25, 95% CI 2.84–3.73), filtered
cigars (OR=2.46, 95% CI 1.88–3.21), snus pouches (OR=2.49, 95%
CI 1.91–3.26), smokeless tobacco (OR=3.72, 95% CI 3.24–4.27), pipes
(OR=3.66, 95% CI 2.94–4.55), and cigarillos (OR=3.37, 95% CI
2.87–3.95). Complementary to these findings, for most non-cigarette
tobacco products, those who perceived it to be more harmful than ci-
garettes were significantly less likely to use that product: e-cigarettes
(OR=0.52, 95% CI, 0.39–0.69), snus pouches (OR=0.40, 95% CI
0.28–0.56), smokeless tobacco (0.41, 95% CI 0.34–0.49), traditional
cigars (OR=0.74, 95% CI 0.64–0.86), pipes (OR=0.62, 95% CI
0.48–0.80) and cigarillos (OR=0.72, 95% CI 0.65–0.81). There was no
association for filtered cigars (OR=0.84, 95% CI 0.69–1.03) and
hookah (OR=0.88, 95% CI 0.75–1.04).
Table 3 presents the prevalence of current non-cigarette use by
perceptions of cigarette harmfulness. A significantly larger proportion
of respondents who said that cigarettes were “very” or “extremely”
harmful used hookah compared to those who said that cigarettes were
“not at all,” “slightly,” or “somewhat” harmful. In contrast, smaller
proportions of respondents who said that cigarettes were “very” or
“extremely” harmful used: filtered cigars, cigarillos, pipes, and dis-
solvables. There was no significant difference in use of: e-cigarettes,
snus pouches, smokeless tobacco, or traditional cigars by perceptions of
the harmfulness of cigarettes.
5. Discussion
The PATH Study is the first nationally representative study ex-
amining perceptions of relative harmfulness across eight non-cigarette
tobacco products. The nationally representative sample and the very
large sample size of the PATH Study allowed for the possibility of
sufficiently powered analyses to examine the perceptions of
40.7 (a) 
17.8 (b) 
13.5 (c) 
12.1 (c) 
10.3 (d) 
 8.6 (e) 
 7.6 (f) 
 7.1 (f) 
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Fig. 1. A: % of Population thinking each product is less harmful than cigarettes Fig. 1B: % of Population thinking each product is more harmful than cigarettes.
N=31,414 for statistical modelling.
*Among those who had heard of the product.
± Products having different letters are significantly different than the product that was ranked immediately below it in terms of perceived harmfulness. For example,
40.7% of people aware of e-cigarettes said e-cigarettes are less harmful than cigarettes while 17.8% of people aware of hookah said hookah is less harmful than
cigarettes. These two percentages are significantly different (p < .05) after controlling for multiple comparisons using a Bonferroni correction.
SOURCE: PATH Wave 1
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harmfulness of a broader range of non-cigarette tobacco products than
past studies using data from adult populations.
Perceptions of the harmfulness of non-cigarette tobacco products
relative to cigarettes varied widely across the eight products. About
41% of respondents who were aware of e-cigarettes believed that e-
cigarettes were less harmful than cigarettes, and almost 18% of those
who were aware of hookah believed that hookah smoking was less
harmful than cigarette smoking. In contrast, fewer U.S. adults perceive
cigars of any type, pipe tobacco, and smokeless tobacco to be less
harmful than cigarettes. Consistent with other studies, only a small
percentage of people believed that smokeless tobacco was less harmful
than cigarettes (8.6%) (Richardson et al., 2014), compared to 27.6%
who believed that smokeless tobacco was more harmful than cigarettes.
Similarly, with the exception of filtered cigar users, being a current user
of a non-cigarette tobacco product was associated with a greater like-
lihood of endorsing the view that the product was less harmful than
cigarettes (Cohn et al., 2015; Nyman et al., 2002; Sterling et al., 2013;
Kaufman et al., 2014).
Few factors were consistently associated with harmfulness percep-
tions of the various products. Previous studies have found that male
respondents were significantly more likely than female respondents to
believe that smokeless tobacco (Richardson et al., 2014; Minaker et al.,
2015) and e-cigarettes (Pearson et al., 2012) are less harmful than
regular cigarettes. The current study found that males and those less
knowledgeable about the health risks of smoking were more likely to
believe that each of the tobacco products (except hookah for males)
were less harmful than cigarettes. Therefore those who are more aware
of the health risks of smoking may also be more likely to believe that
other tobacco products are also harmful. Consistent with other research
(Aljarrah et al., 2009; Smith-Simone et al., 2008; Sutfin et al., 2011;
Cohn et al., 2015; Weinstein et al., 2005), current tobacco use was also
associated with a greater likelihood of believing that each of the to-
bacco products was less harmful than cigarettes for most products.
The factors associated with perceptions of harmfulness were, in
many instances, product-specific. For example, younger respondents
were more likely to believe that e-cigarettes and hookah are less
harmful than cigarettes. Consistent with previous research (Aljarrah
et al., 2009), we found that respondents with higher education levels
were more likely to believe that each product (except smokeless to-
bacco) was less harmful than cigarettes. Consistent with research ex-
amining absolute perceptions of product harm, Black respondents were
more likely to believe that cigarillos are less harmful. However,
whereas Black respondents have been found to have greater absolute
perceptions of the harmfulness of smokeless, cigars, roll your own,
pipes and hookah but not e-cigarettes, the current study found that
Black respondents are less likely to believe that e-cigarettes, pipes and
dissolvables are less harmful than cigarettes. These findings point to the
importance of examining both absolute and relative perceptions of
harmfulness and can inform educational campaigns about the harm-
fulness of non-cigarette tobacco products to certain sub-populations.
For every non-cigarette tobacco product examined, a lower per-
ception of product harmfulness, in comparison to cigarettes, was asso-
ciated with a greater likelihood of using that product. However, higher
perceptions of the harmfulness of cigarettes was only associated with a
greater likelihood of using hookah. The PATH Study longitudinal data
may allow us to examine whether product harmfulness perceptions
predict future use of products and the extent to which marketing and
other factors influence perceptions of harmfulness.
6. Limitations
In the PATH Study Adult Questionnaire, “don't know” responses
were not given as an initial response option; rather, respondents who
did not respond had the option of then saying “don't know” in a follow-
up question. It is therefore unclear how strongly respondents may hold
a given belief. In previous research, a high proportion of respondents
indicated that they “don't know” whether these products are less
harmful (O'Connor et al., 2007; Borland et al., 2011; Eissenberg et al.,
2009). However, in our analyses, only those respondents who were
aware of each of the products were included. The responses therefore
represent the respondents' impression of the harmfulness of the product
as it compares to the harm of cigarettes. The PATH Study Wave 1 Adult
questionnaire did not include measures of absolute harm but rather
compared the harmfulness of non-cigarette tobacco products relative to
cigarettes. Previous research suggests that the direct comparative
measure used in the PATH Study would provide a more conservative
measure of the harm perception associated with these products, relative
to cigarettes, than if indirect measures had been used (Kaufman et al.,
2016). Further, the comparative nature of the items included in the
PATH Study used cigarettes as the referent, so it is unknown how
perceptions of harmfulness may differ if the reference is different (e.g.
no tobacco) [40].
This paper reports cross-sectional data, which precludes judgments
about causal relationships. Future waves of the PATH Study may allow
analyses with greater potential to discern causal direction in observed
associations, to address, for example, the extent to which perceiving a
product to be less harmful than cigarettes leads to a greater likelihood
of trial and regular use of that product, and/or the extent to which
Table 3
Prevalence of non-cigarette use and cigarette smoking by perceptions of cigarette harmfulness± (n=17,690). SOURCE: PATH Study Wave 1.
Perceptions of Cigarette harmfulness
Not at all/slightly/somewhat harmful Very/extremely harmful Rao-Scott ChiSq Test
Current Tobacco Product Use* % (95% CI) % (95% CI) ChiSq p-value
E-cigarettes 19.1 (17.8, 20.4) 19.9 (19.0, 20.8) 1.08 0.298
Snus pouches 2.8 (2.2, 3.4) 2.7 (2.3, 3.0) 0.11 0.743
Smokeless 10.7 (9.6, 12.0) 11.1 (10.3, 12.0) 0.27 0.602
Traditional cigars 14.9 (13.8, 16.1) 16.2 (15.4, 17.0) 2.82 0.093
Filtered cigars 9.6 (8.6, 10.7) 6.4 (5.9, 6.9) 47.92 <0.001
Cigarillos 18.6 (17.2, 20.0) 14.5 (13.8, 15.3) 26.65 <0.001
Pipe 5.3 (4.5, 6.2) 3.5 (3.2, 3.9) 20.20 <0.001
Hookah 11.5 (10.4, 12.7) 15.8 (14.9, 16.7) 45.50 <0.001
Dissolvables 0.6 (0.4, 0.9) 0.2 (0.2, 0.3) 9.72 0.002
Cigarettes 88.0 (86.8, 89.1) 71.9 (70.8, 72.9) 291.05 <0.001
± among current tobacco users who currently use one or more tobacco products.
*Current users of non-cigarette tobacco products were defined on the basis of two questions: ever use and current someday use/current daily use. Respondents who
had ever used the product and currently used it every day or some days were classified as current users. Current cigarette smokers were defined differently, relying on
an additional restriction of established use (i.e., > 100 cigarettes in lifetime). Current cigarette smokers were those respondents who had smoked at least 100
cigarettes in their lifetimes and who currently smoke every day or some days.
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product use leads to a greater likelihood of perceiving that product to
be less harmful than cigarettes.
7. Implications
Perceptions of harmfulness varied widely across eight types of non-
cigarette tobacco products. We observed an association between per-
ceptions of product harmfulness and product use, but further long-
itudinal research may be useful to determine whether such perceptions
are useful predictors of future product adoption. These results point to
the potential value of enhancing knowledge, within the U.S. population,
of the harm of tobacco products to prevent tobacco use and to en-
courage tobacco users to quit, through providing new information
about the harms that may not be widely known and/or through coun-
tering misperceptions that may exist.
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